Placental cell treatment for COVID-19 symptoms
Part of Infections, Lungs & breathing clinical trials.
This study tests a treatment made from placental cells that may help reduce COVID-19 symptoms. It is for adults with mild to moderate symptoms who are overweight or obese.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a BMI between 25 and 39.9
- You have had COVID-19 symptoms for more than 2 days but no longer than 10 days
- You have tested positive for COVID-19 with two rapid antigen tests taken within 2 hours of each other
- You have at least two COVID-19 symptoms that are moderate or severe
- If you are a woman of childbearing age, you must have a negative pregnancy test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether donated “recovered patient” plasma (antibodies from people who had COVID-19) can improve outcomes for people hospitalized with COVID-19. It focuses on patients early in their illness who need a small amount of oxygen.
This study tests a new antibody medicine for people with COVID-19 who are at high risk of getting very sick. If you qualify, you would receive the study drug or a placebo (inactive substance) to see if it helps you recover without needing to go to the hospital.
This trial studies whether PF-07321332 (with ritonavir) helps children under 18 who have COVID-19 at home but are at high risk of severe illness. It looks at whether starting treatment early can reduce progression to worse disease.
This trial tests whether Codivir can help people hospitalized with moderate COVID-19 recover better than a placebo (inactive pill). It will compare outcomes while participants receive standard hospital care.
This trial tests whether immune-supporting treatment made from exosomes can help people with critically severe COVID-19 and lung damage. If you qualify, you may receive this therapy as part of the study to see if it improves outcomes.
This trial studies whether a new treatment using stem cells from healthy donors can help people with severe or critical COVID-19. The goal is to see if it reduces inflammation and helps you recover faster.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.